{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for mafodotin in Note (approximate match)
Status:
Investigational
Source:
NCT03336606: Phase 1 Interventional Active, not recruiting Head and Neck Cancer
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
USAN:DENINTUZUMAB [USAN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01786096: Phase 1 Interventional Completed Burkitt Lymphoma
(2013)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT01015911: Phase 1 Interventional Completed Carcinoma, Renal Cell
(2009)
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
BLA761158
(2020)
Source URL:
First approved in 2020
Source:
BLA761158
Source URL:
Class:
PROTEIN
